Senile dementia

1 trials 1 recruiting MedDRA PT
1 Registered trials
1 Recruiting
1 Unique sponsors
2 Unique IMPs
0 Commercial trials
Drug classes (ATC)
V Various (ATC V) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 2 substances
Phase IV: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase IV

1 trial
  • Deutsches Zentrum Fuer Neurodegenerative Erkrankungen e.V. Academic
    FLORBETABEN (18F); FLUTEMETAMOL (18F)
    2023-503705-10-00 1 country 2024 n=1,126
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Deutsches Zentrum Fuer Neurodegenerative Erkrankungen e.V. Academic 1 Phase IV 1
New trials by year
2024
1
← All indication landscapes